These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 5454437

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M, Kinukawa M, Kanazawa T, Maruyama K, Miyagi M, Miyata H, Ujiie A.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Clinical study of the anti-arrhythmic effects of oral amiodarone].
    Nicolaescu V, Câmpeanu A, Constantinescu I.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981 Nov; 33(5):355-64. PubMed ID: 6122247
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
    Masuhara K, Ohno T, Hamaguchi K, Katoh K, Kashiwada K, Takahashi S, Tanaka Y, Someya K, Ogata H.
    Int J Clin Pharmacol Res; 1995 Nov; 15(3):103-13. PubMed ID: 8847151
    [Abstract] [Full Text] [Related]

  • 49. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G, Singh BN.
    Heart Lung; 1980 Nov; 9(3):469-74. PubMed ID: 6901519
    [No Abstract] [Full Text] [Related]

  • 50. Severe hypoglycemia associated with disopyramide.
    Nappi JM, Dhanani S, Lovejoy JR, VanderArk C.
    West J Med; 1983 Jan; 138(1):95-7. PubMed ID: 6404062
    [No Abstract] [Full Text] [Related]

  • 51. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G, Belli R, Pavia M, Rey L, Ravera A, Possavino G, Idone P.
    G Ital Cardiol; 1982 Jan; 12(7):509-19. PubMed ID: 7169147
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Ajmalin--a new anti-arrhythmic drug].
    Levander-Lindgren M.
    Lakartidningen; 1966 Mar 16; 63(11):1059-66. PubMed ID: 5917916
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Use of intravenous disopyramide in the treatment of symptomatic refractory ventricular arrhythmia].
    Leone A.
    Minerva Cardioangiol; 1984 Mar 16; 32(3):151-6. PubMed ID: 6728204
    [No Abstract] [Full Text] [Related]

  • 60. [Propafenone: a new anti-arrhythmic drug for treatment of ectopic ventricular beats].
    Molinis G, Valente M, Tuniz D, Maisano G.
    Cardiologia; 1982 Mar 16; 27(2):211-7. PubMed ID: 6892412
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.